Etoricoxib Farmoz

Etoricoxib

Symptomatic relief of OA, RA, ankylosing spondylitis, & pain & signs of inflammation associated w/ acute gouty arthritis. Short-term treatment of moderate pain associated w/ dental surgery.

Adult & adolescent ≥16 yr Use at the lowest effective dose for shortest possible time.

May be taken with or without food.

Patients w/ severe heart failure. Treatment of peri-operative pain in the CABG setting. 3rd trimester of pregnancy.

Increased risk of serious CV thrombotic events, MI, & stroke; serious GI adverse events including bleeding, ulceration, & perforation of the stomach or intestines. Risk of renal papillary necrosis & other renal injury w/ long-term NSAIDs administration. Renal toxicity in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. Not recommended in patients w/ advanced renal disease. Caution during 1st & 2nd trimesters of pregnancy, particularly from the middle to end of 2nd trimester (onset at approx 20 wk) due to possible fetal renal dysfunction leading to oligohydramnios &, in some cases, neonatal renal impairment or failure.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

M01AH05 - etoricoxib ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, coxibs.

P₁S₁S₃